Xenogeneic cell-based medicinal products

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberCHMP/CPWP/83508/09
Effective from01/01/2010
KeywordsXenogeneic, cell therapy, quality, nonclinical, clinical, transgenic animals
DescriptionThis document addresses the scientific requirements for medicinal products that contain viable animal cells or tissues as an active substance (xenogeneic cell-based medicinal products). It provides general principles for the development and assessment of xenogeneic cell-based products without prejudice to medical practice or national legislation, which may be applicable.

Document history

First version

Current version

Adopted guideline

Draft guideline

Concept paper

In operation: 01/01/2010–present

Published: 27/02/2009

Published: 17/12/2003

Related content

How helpful is this page?

Average rating:

 Based on 25 ratings

Add your rating:

See all ratings
5 ratings
5 ratings
5 ratings
5 ratings
5 ratings

Tell us more